Classification and clinical features of adverse drug reactions in patients with ulcerative colitis treated with 5‐aminosalicylate acid: a single-center, observational study-Reference-Cited by-同舟云学术

Classification and clinical features of adverse drug reactions in patients with ulcerative colitis treated with 5‐aminosalicylate acid: a single-center, observational study

Published:2021-11-09 Issue:2 Volume:57 Page:190-196
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Tsujii Yuri¹,Nishida Tsutomu¹^ORCID,Osugi Naoto¹,Fujii Yoshifumi¹,Sugimoto Aya¹,Nakamatsu Dai¹,Mukai Kaori¹,Matsumoto Kengo¹,Hayashi Shiro²,Yamamoto Masashi¹,Nakajima Sachiko¹

Affiliation:

1. Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Japan

2. Department of Gastroenterology and Internal Medicine, Hayashi Clinic, Suita, Japan

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2021.1998601

Reference21 articles.

1. Short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis

2. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020